Instil Bio Inc (TIL)
26.15
+1.39
(+5.61%)
USD |
NASDAQ |
Nov 22, 16:00
25.91
-0.24
(-0.92%)
After-Hours: 20:00
Instil Bio Free Cash Flow: -68.58M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -68.58M |
| June 30, 2024 | -58.03M |
| March 31, 2024 | -73.96M |
| December 31, 2023 | -102.69M |
| September 30, 2023 | -139.24M |
| June 30, 2023 | -185.73M |
| March 31, 2023 | -232.60M |
| December 31, 2022 | -264.75M |
| Date | Value |
|---|---|
| September 30, 2022 | -276.02M |
| June 30, 2022 | -261.08M |
| March 31, 2022 | -228.40M |
| December 31, 2021 | -179.97M |
| September 30, 2021 | -180.81M |
| June 30, 2021 | -141.21M |
| March 31, 2021 | -104.04M |
| December 31, 2020 | -80.43M |
Free Cash Flow Range, Past 5 Years
-276.02M
Minimum
Sep 2022
-58.03M
Maximum
Jun 2024
-161.10M
Average
-160.59M
Median
Free Cash Flow Benchmarks
| Merck & Co Inc | 14.84B |
| Elite Pharmaceuticals Inc | 1.685M |
| BioCardia Inc | -7.309M |
| Zevra Therapeutics Inc | -69.57M |
| NovaBay Pharmaceuticals Inc | -4.812M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -20.13M |
| Cash from Investing (Quarterly) | 19.81M |
| Cash from Financing (Quarterly) | 0.159M |
| Free Cash Flow Per Share (Quarterly) | -4.631 |
| Free Cash Flow Yield | -40.32% |